The Valens Company (TSX: VLNS) announced that they will be reporting their second quarter financials before market open on July 14th. Results will follow the firms first quarter performance, which saw the company record revenues of $20.0 million, and negative adjusted EBITDA of $2.2 million.
Analysts have a consensus C$4.44 12-month price target on the company, via a total of 9 analysts, with one analyst having a strong buy rating, seven having buy ratings, and one analyst has a hold rating. The street high comes from Stifel-GMP with a C$5.75 price target, and the lowest target comes from Raymond James with a C$3.50 price target.
Seven analysts have revenue estimates for the second quarter. The mean between all 7 is C$21.37 million; this number has been revised downwards from C$27.27 million at the start of the year. The high sits at C$24.50 million and the lowest revenue estimate sits at C$19.50 million.
Four analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 25.47%, with this number being revised down from 34.50% at the start of the year. Street high sits at 26.10% while the lowest is 24%.
Onto EBITDA estimates, there are currently seven analysts who have second quarter EBITDA estimates. The mean is currently -C$2.4 million, with this number being lower than the C$3.73 million estimate at the start of the year. Street high sits at C$0.5 million while the lowest comes in at -C$4.02 million.
Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
